csa Search Results


94
JULABO GmbH dyneo dd 200f 4 circulator
Dyneo Dd 200f 4 Circulator, supplied by JULABO GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/DYNEO+DD-200F/arxiv__2602__12086-91-20-19
Average 94 stars, based on 1 article reviews
dyneo dd 200f 4 circulator - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
OriGene human grp75 tagged orf
NIC1 signaling regulates ER calcium levels. Schematic (I) Timeline of experiments assessing changes in ER calcium levels. Schematic (II) Timeline of experiments, in cells treated with siRNA before assessing changes in ER calcium levels. (A) Fluo4 fluorescence in HEK cells expressing NIC1-RFP ( ) or RFP ( ), at time-t (F t ) relative to onset (F 0 ) measured in calcium free medium at baseline and in response to 2 μM TG. (B) YFP/CFP ratio in HEK cells co-transfected with D1ER and NIC1-RFP ( ) or, Bcl-xL-RFP ( ) or, RFP ( ) and cultured for 36 h before imaging. (C) Schematic (not to scale) depicting - IP3R3, <t>Grp75,</t> VDAC1 and MCU- in the context of ER and mitochondria. (D–F) Ratio of YFP/CFP fluorescence in HEK cells, imaged 36 h after co-transfection with D1ER and NIC1-RFP ( ) or RFP ( ), in cells pre-treated with siRNA to IP3R3 (D-ii) or VDAC1 (E-ii) or MCU (F-ii) or scrambled control ( D-F-i , NIC1-RFP ( ) and RFP ( ). (D–F iii) Percent mRNA levels of the genes as shown in panels, in cells treated with siRNA to IP3R3 ( D , N=3) or VDAC1 ( E , N=2) or MCU ( F , N=3) and scrambled control. Data plotted as mean ± SD of the indicated number of cells in 6-12 fields across three (A, D, F) or two (B, D) independent experiments. *** indicates significant difference at all time points with p-values ≤0.001 and ns: not significant, examined using unpaired student’s t-test.
Human Grp75 Tagged Orf, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/Grp75+(HSPA9)+(NM_004134)+Human+Tagged+ORF+Clone/pmc08866856-62-0-8
Average 90 stars, based on 1 article reviews
human grp75 tagged orf - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

94
Proteintech 14887 1 ap
NIC1 signaling regulates ER calcium levels. Schematic (I) Timeline of experiments assessing changes in ER calcium levels. Schematic (II) Timeline of experiments, in cells treated with siRNA before assessing changes in ER calcium levels. (A) Fluo4 fluorescence in HEK cells expressing NIC1-RFP ( ) or RFP ( ), at time-t (F t ) relative to onset (F 0 ) measured in calcium free medium at baseline and in response to 2 μM TG. (B) YFP/CFP ratio in HEK cells co-transfected with D1ER and NIC1-RFP ( ) or, Bcl-xL-RFP ( ) or, RFP ( ) and cultured for 36 h before imaging. (C) Schematic (not to scale) depicting - IP3R3, <t>Grp75,</t> VDAC1 and MCU- in the context of ER and mitochondria. (D–F) Ratio of YFP/CFP fluorescence in HEK cells, imaged 36 h after co-transfection with D1ER and NIC1-RFP ( ) or RFP ( ), in cells pre-treated with siRNA to IP3R3 (D-ii) or VDAC1 (E-ii) or MCU (F-ii) or scrambled control ( D-F-i , NIC1-RFP ( ) and RFP ( ). (D–F iii) Percent mRNA levels of the genes as shown in panels, in cells treated with siRNA to IP3R3 ( D , N=3) or VDAC1 ( E , N=2) or MCU ( F , N=3) and scrambled control. Data plotted as mean ± SD of the indicated number of cells in 6-12 fields across three (A, D, F) or two (B, D) independent experiments. *** indicates significant difference at all time points with p-values ≤0.001 and ns: not significant, examined using unpaired student’s t-test.
14887 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/GRP75+Antibody/pmc12953705-39-11-9
Average 94 stars, based on 1 article reviews
14887 1 ap - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology rpl10a
NIC1 signaling regulates ER calcium levels. Schematic (I) Timeline of experiments assessing changes in ER calcium levels. Schematic (II) Timeline of experiments, in cells treated with siRNA before assessing changes in ER calcium levels. (A) Fluo4 fluorescence in HEK cells expressing NIC1-RFP ( ) or RFP ( ), at time-t (F t ) relative to onset (F 0 ) measured in calcium free medium at baseline and in response to 2 μM TG. (B) YFP/CFP ratio in HEK cells co-transfected with D1ER and NIC1-RFP ( ) or, Bcl-xL-RFP ( ) or, RFP ( ) and cultured for 36 h before imaging. (C) Schematic (not to scale) depicting - IP3R3, <t>Grp75,</t> VDAC1 and MCU- in the context of ER and mitochondria. (D–F) Ratio of YFP/CFP fluorescence in HEK cells, imaged 36 h after co-transfection with D1ER and NIC1-RFP ( ) or RFP ( ), in cells pre-treated with siRNA to IP3R3 (D-ii) or VDAC1 (E-ii) or MCU (F-ii) or scrambled control ( D-F-i , NIC1-RFP ( ) and RFP ( ). (D–F iii) Percent mRNA levels of the genes as shown in panels, in cells treated with siRNA to IP3R3 ( D , N=3) or VDAC1 ( E , N=2) or MCU ( F , N=3) and scrambled control. Data plotted as mean ± SD of the indicated number of cells in 6-12 fields across three (A, D, F) or two (B, D) independent experiments. *** indicates significant difference at all time points with p-values ≤0.001 and ns: not significant, examined using unpaired student’s t-test.
Rpl10a, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/RPL10A+Rabbit+pAb/pmc10229589-318-11-14
Average 94 stars, based on 1 article reviews
rpl10a - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

92
Proteintech rabbit anti rps4x es4
NIC1 signaling regulates ER calcium levels. Schematic (I) Timeline of experiments assessing changes in ER calcium levels. Schematic (II) Timeline of experiments, in cells treated with siRNA before assessing changes in ER calcium levels. (A) Fluo4 fluorescence in HEK cells expressing NIC1-RFP ( ) or RFP ( ), at time-t (F t ) relative to onset (F 0 ) measured in calcium free medium at baseline and in response to 2 μM TG. (B) YFP/CFP ratio in HEK cells co-transfected with D1ER and NIC1-RFP ( ) or, Bcl-xL-RFP ( ) or, RFP ( ) and cultured for 36 h before imaging. (C) Schematic (not to scale) depicting - IP3R3, <t>Grp75,</t> VDAC1 and MCU- in the context of ER and mitochondria. (D–F) Ratio of YFP/CFP fluorescence in HEK cells, imaged 36 h after co-transfection with D1ER and NIC1-RFP ( ) or RFP ( ), in cells pre-treated with siRNA to IP3R3 (D-ii) or VDAC1 (E-ii) or MCU (F-ii) or scrambled control ( D-F-i , NIC1-RFP ( ) and RFP ( ). (D–F iii) Percent mRNA levels of the genes as shown in panels, in cells treated with siRNA to IP3R3 ( D , N=3) or VDAC1 ( E , N=2) or MCU ( F , N=3) and scrambled control. Data plotted as mean ± SD of the indicated number of cells in 6-12 fields across three (A, D, F) or two (B, D) independent experiments. *** indicates significant difference at all time points with p-values ≤0.001 and ns: not significant, examined using unpaired student’s t-test.
Rabbit Anti Rps4x Es4, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/RPL10A+Antibody/pmc06894925-255-25-27
Average 92 stars, based on 1 article reviews
rabbit anti rps4x es4 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

95
MedChemExpress cyclosporin a
Figure 5. S100a8/9 activated calcineurin/NFAT signaling pathway during phenylephrine-induced hypertrophy of cardiomyocytes in vitro. A, Cell areas of NRCMs treated with several inhibitors of hypertrophy-related kinases (n=5). <t>cyclosporin</t> <t>A</t> (an inhibitor of calcineurin), VIVIT (an inhibitor of NFAT), CCT129957 (an inhibitor of PLCγ), PD169316 (an inhibitor of p38), SP600125 (an inhibitor of JNK), U0126 (an inhibitor of ERK), BMS-345541 (an inhibitor of NF-κB), and AKTi (an inhibitor of AKT) were used. B, mRNA levels of atrial natriuretic peptide (ANP) in indicated groups (n=5). C and D, Calcineurin activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). E and F, NFAT transcriptional activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). G and H, mRNA level of calcineurin 1 (RCAN1) in the hearts following AB with overexpression or knockdown of S100a9 (n=6). I, Representative Western blots and the statistical results of the protein levels (n=6). Values represent the mean±SEM. *P<0.05 vs the matched control group. AB indicates aortic banding; ANP, atrial natriuretic peptide; NF-κB, nuclear factor-κB; NFAT, nuclear factor of activated T cells; NRCM, neonatal rat cardiomyocyte; PCNA, proliferating cell nuclear antigen; PLCγ, phospholipase C-γ; P-PLCγ, phospho-PLCγ; RCAN1, regulator of calcineurin 1; and S100a8/9, S100 calcium binding protein a8/9.
Cyclosporin A, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/Cyclosporin+A/10__1161_slash_jaha__122__028006-40-9-14
Average 95 stars, based on 1 article reviews
cyclosporin a - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti glucose regulated protein 75
Figure 5. S100a8/9 activated calcineurin/NFAT signaling pathway during phenylephrine-induced hypertrophy of cardiomyocytes in vitro. A, Cell areas of NRCMs treated with several inhibitors of hypertrophy-related kinases (n=5). <t>cyclosporin</t> <t>A</t> (an inhibitor of calcineurin), VIVIT (an inhibitor of NFAT), CCT129957 (an inhibitor of PLCγ), PD169316 (an inhibitor of p38), SP600125 (an inhibitor of JNK), U0126 (an inhibitor of ERK), BMS-345541 (an inhibitor of NF-κB), and AKTi (an inhibitor of AKT) were used. B, mRNA levels of atrial natriuretic peptide (ANP) in indicated groups (n=5). C and D, Calcineurin activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). E and F, NFAT transcriptional activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). G and H, mRNA level of calcineurin 1 (RCAN1) in the hearts following AB with overexpression or knockdown of S100a9 (n=6). I, Representative Western blots and the statistical results of the protein levels (n=6). Values represent the mean±SEM. *P<0.05 vs the matched control group. AB indicates aortic banding; ANP, atrial natriuretic peptide; NF-κB, nuclear factor-κB; NFAT, nuclear factor of activated T cells; NRCM, neonatal rat cardiomyocyte; PCNA, proliferating cell nuclear antigen; PLCγ, phospholipase C-γ; P-PLCγ, phospho-PLCγ; RCAN1, regulator of calcineurin 1; and S100a8/9, S100 calcium binding protein a8/9.
Anti Glucose Regulated Protein 75, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/Grp75+Rabbit+mAb/pmc10557178-1-0-13
Average 94 stars, based on 1 article reviews
anti glucose regulated protein 75 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
JULABO GmbH dyneo dd 1000f refrigeration circulation thermostat
Figure 5. S100a8/9 activated calcineurin/NFAT signaling pathway during phenylephrine-induced hypertrophy of cardiomyocytes in vitro. A, Cell areas of NRCMs treated with several inhibitors of hypertrophy-related kinases (n=5). <t>cyclosporin</t> <t>A</t> (an inhibitor of calcineurin), VIVIT (an inhibitor of NFAT), CCT129957 (an inhibitor of PLCγ), PD169316 (an inhibitor of p38), SP600125 (an inhibitor of JNK), U0126 (an inhibitor of ERK), BMS-345541 (an inhibitor of NF-κB), and AKTi (an inhibitor of AKT) were used. B, mRNA levels of atrial natriuretic peptide (ANP) in indicated groups (n=5). C and D, Calcineurin activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). E and F, NFAT transcriptional activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). G and H, mRNA level of calcineurin 1 (RCAN1) in the hearts following AB with overexpression or knockdown of S100a9 (n=6). I, Representative Western blots and the statistical results of the protein levels (n=6). Values represent the mean±SEM. *P<0.05 vs the matched control group. AB indicates aortic banding; ANP, atrial natriuretic peptide; NF-κB, nuclear factor-κB; NFAT, nuclear factor of activated T cells; NRCM, neonatal rat cardiomyocyte; PCNA, proliferating cell nuclear antigen; PLCγ, phospholipase C-γ; P-PLCγ, phospho-PLCγ; RCAN1, regulator of calcineurin 1; and S100a8/9, S100 calcium binding protein a8/9.
Dyneo Dd 1000f Refrigeration Circulation Thermostat, supplied by JULABO GmbH, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/DYNEO+DD-1000F/10__3390_slash_app16083742-171-8-13
Average 93 stars, based on 1 article reviews
dyneo dd 1000f refrigeration circulation thermostat - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology ercc8
Pedigree and genetic mutation of the family with keratoconus and congenital cataracts. ( A ) Pedigree. ( B ) Sanger sequencing confirms the c.394-398del (p. L132Nfs*6) mutation identified by WES (I-2 and II-1) and HRM (KC5). ( C ) Cross-species comparison of the region of <t>ERCC8</t> indicates that the identified mutation affects highly conserved residues. ( D ) Domain analysis of the p. L132Nfs*6 mutation. ( E ) The 3D structures of mutant and wild type protein.
Ercc8, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/CSA+Antibody/pmc09728497-57-9-11
Average 93 stars, based on 1 article reviews
ercc8 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

92
ABclonal Biotechnology anti ercc8 csa a6884
Pedigree and genetic mutation of the family with keratoconus and congenital cataracts. ( A ) Pedigree. ( B ) Sanger sequencing confirms the c.394-398del (p. L132Nfs*6) mutation identified by WES (I-2 and II-1) and HRM (KC5). ( C ) Cross-species comparison of the region of <t>ERCC8</t> indicates that the identified mutation affects highly conserved residues. ( D ) Domain analysis of the p. L132Nfs*6 mutation. ( E ) The 3D structures of mutant and wild type protein.
Anti Ercc8 Csa A6884, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/ERCC8+Rabbit+pAb/pmc11162794-82-18-24
Average 92 stars, based on 1 article reviews
anti ercc8 csa a6884 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti hspa9 antibody
( A ) Schematic of capturing EBERs ncRNA cofactors via annotated tandem (MS2) mass spectrum. ( B ) The scatter plot displays the cofactors associated with EBERs ncRNA captured by MASS. ( C ) GO term enrichment analysis of EBERs cofactors. The x -axis represents -log10 (P-value) from the hypergeometric test. ( D ) Display of the binding peak of EBV cofactors <t>HSPA9</t> and NCL in EBERs -NC cells and EBERs -KD cells, overlapping with EBERs-binding peaks. ( E ) Display of the binding peak of EBERs , without detecting peaks of cofactors NCL in EBERs -KD cells and EBERs -NC cells. ( F ) Bar charts display the proportion of cofactors HSPA9 and NCL that overlapped with EBERs targeting regions. n indicates the total number of peaks for HSPA9 and NCL captured by ChIP-seq. ( G ) Box plots illustrating the change of binding signal of HSPA9 and NCL before and after EBERs knockdown. Two-sided Wilcoxon tests are performed. Each box plot highlights the median (inside line), the 25–75th percentiles (box), and the minima/maxima values within 1.5× the interquartile range (IQR) of the box (whiskers). ( H ) Schematic representation of NCL-interacted chromatin RNA assay (termed NCL-RNA). ( I ) Basic Browser View of EBERs ncRNA and mRNA, such as LMP-2, as observed in RNA-seq and NCL-RNA. ( J ) Enrichment analysis of EBERs ncRNA is depicted by the ratio of RPKM of EBERs compared to other mRNAs, with t tests performed. Bars represent the mean values of the data, while error bars indicate the standard deviation (SD). ( K ) Schematic illustration of NCL truncations and the principle of EMSA. ( L ) EMSA results demonstrate the interaction at varying concentrations of NCL protein mixed with 1 μM EBERs . .
Anti Hspa9 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/csa/HSPA9+Rabbit+pAb/pmc12216251-24-0-3
Average 94 stars, based on 1 article reviews
anti hspa9 antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


NIC1 signaling regulates ER calcium levels. Schematic (I) Timeline of experiments assessing changes in ER calcium levels. Schematic (II) Timeline of experiments, in cells treated with siRNA before assessing changes in ER calcium levels. (A) Fluo4 fluorescence in HEK cells expressing NIC1-RFP ( ) or RFP ( ), at time-t (F t ) relative to onset (F 0 ) measured in calcium free medium at baseline and in response to 2 μM TG. (B) YFP/CFP ratio in HEK cells co-transfected with D1ER and NIC1-RFP ( ) or, Bcl-xL-RFP ( ) or, RFP ( ) and cultured for 36 h before imaging. (C) Schematic (not to scale) depicting - IP3R3, Grp75, VDAC1 and MCU- in the context of ER and mitochondria. (D–F) Ratio of YFP/CFP fluorescence in HEK cells, imaged 36 h after co-transfection with D1ER and NIC1-RFP ( ) or RFP ( ), in cells pre-treated with siRNA to IP3R3 (D-ii) or VDAC1 (E-ii) or MCU (F-ii) or scrambled control ( D-F-i , NIC1-RFP ( ) and RFP ( ). (D–F iii) Percent mRNA levels of the genes as shown in panels, in cells treated with siRNA to IP3R3 ( D , N=3) or VDAC1 ( E , N=2) or MCU ( F , N=3) and scrambled control. Data plotted as mean ± SD of the indicated number of cells in 6-12 fields across three (A, D, F) or two (B, D) independent experiments. *** indicates significant difference at all time points with p-values ≤0.001 and ns: not significant, examined using unpaired student’s t-test.

Journal: Frontiers in Immunology

Article Title: Notch1 Modulation of Cellular Calcium Regulates Mitochondrial Metabolism and Anti-Apoptotic Activity in T-Regulatory Cells

doi: 10.3389/fimmu.2022.832159

Figure Lengend Snippet: NIC1 signaling regulates ER calcium levels. Schematic (I) Timeline of experiments assessing changes in ER calcium levels. Schematic (II) Timeline of experiments, in cells treated with siRNA before assessing changes in ER calcium levels. (A) Fluo4 fluorescence in HEK cells expressing NIC1-RFP ( ) or RFP ( ), at time-t (F t ) relative to onset (F 0 ) measured in calcium free medium at baseline and in response to 2 μM TG. (B) YFP/CFP ratio in HEK cells co-transfected with D1ER and NIC1-RFP ( ) or, Bcl-xL-RFP ( ) or, RFP ( ) and cultured for 36 h before imaging. (C) Schematic (not to scale) depicting - IP3R3, Grp75, VDAC1 and MCU- in the context of ER and mitochondria. (D–F) Ratio of YFP/CFP fluorescence in HEK cells, imaged 36 h after co-transfection with D1ER and NIC1-RFP ( ) or RFP ( ), in cells pre-treated with siRNA to IP3R3 (D-ii) or VDAC1 (E-ii) or MCU (F-ii) or scrambled control ( D-F-i , NIC1-RFP ( ) and RFP ( ). (D–F iii) Percent mRNA levels of the genes as shown in panels, in cells treated with siRNA to IP3R3 ( D , N=3) or VDAC1 ( E , N=2) or MCU ( F , N=3) and scrambled control. Data plotted as mean ± SD of the indicated number of cells in 6-12 fields across three (A, D, F) or two (B, D) independent experiments. *** indicates significant difference at all time points with p-values ≤0.001 and ns: not significant, examined using unpaired student’s t-test.

Article Snippet: Human Grp75 Tagged ORF Clone was obtained from Origene (RG201397, MD, USA) and sub-cloned into pBABE vector.

Techniques: Fluorescence, Expressing, Transfection, Cell Culture, Imaging, Cotransfection, Control

NIC1-mediated Treg survival requires IP3Rs, Grp75 and MCU. (A) Percent apoptotic nuclei in activated WT Tregs cultured without IL-2 for 24 h with vehicle control (UT) or, 5 μM Xestospongin C or, 10 μM MKT-077 or, 10 μM Ru360. (B, C) Percent apoptotic nuclei in Notch1 -/- Tregs transduced with pBABE or NIC1-NES (B) or pMIG or Bcl-xL (C), and cultured without IL-2 for 24 h with vehicle control, or 5 μM Xestospongin C or, 10 μM MKT-077 or, 10 μM Ru360. (D) Basal and maximum OCR, computed as described in methods, in Notch1 -/- Tregs transduced with pBABE or NIC1-NES. (E) Immunoblot of whole cell lysates prepared from activated WT Tregs cells cultured with or without 10 μM GSI-X or 10 μM MKT-077 for 8 h and the samples run in duplicate. Membrane was probed either for (p)PDH, Notch1 and Tubulin (E-i) or PDH, Notch1 and Tubulin (E-ii) . The immunoblot is representative of two independent experiments. Data are mean ± SD of three independent experiments (A–C) and readings in 4 wells from two independent experiments (D). ** indicates significant difference with p-value ≤0.01 and ns, not significant, examined using unpaired student’s t-test.

Journal: Frontiers in Immunology

Article Title: Notch1 Modulation of Cellular Calcium Regulates Mitochondrial Metabolism and Anti-Apoptotic Activity in T-Regulatory Cells

doi: 10.3389/fimmu.2022.832159

Figure Lengend Snippet: NIC1-mediated Treg survival requires IP3Rs, Grp75 and MCU. (A) Percent apoptotic nuclei in activated WT Tregs cultured without IL-2 for 24 h with vehicle control (UT) or, 5 μM Xestospongin C or, 10 μM MKT-077 or, 10 μM Ru360. (B, C) Percent apoptotic nuclei in Notch1 -/- Tregs transduced with pBABE or NIC1-NES (B) or pMIG or Bcl-xL (C), and cultured without IL-2 for 24 h with vehicle control, or 5 μM Xestospongin C or, 10 μM MKT-077 or, 10 μM Ru360. (D) Basal and maximum OCR, computed as described in methods, in Notch1 -/- Tregs transduced with pBABE or NIC1-NES. (E) Immunoblot of whole cell lysates prepared from activated WT Tregs cells cultured with or without 10 μM GSI-X or 10 μM MKT-077 for 8 h and the samples run in duplicate. Membrane was probed either for (p)PDH, Notch1 and Tubulin (E-i) or PDH, Notch1 and Tubulin (E-ii) . The immunoblot is representative of two independent experiments. Data are mean ± SD of three independent experiments (A–C) and readings in 4 wells from two independent experiments (D). ** indicates significant difference with p-value ≤0.01 and ns, not significant, examined using unpaired student’s t-test.

Article Snippet: Human Grp75 Tagged ORF Clone was obtained from Origene (RG201397, MD, USA) and sub-cloned into pBABE vector.

Techniques: Cell Culture, Control, Transduction, Western Blot, Membrane

Notch1 activity regulates Grp75 protein levels. (A) Immunoblots of whole cell lysates prepared from activated Notch1 +/+ (Cre-ve) and Notch1 -/- (Cre+ve; Cd4-Cre::Notch1 lox/lox ) Tregs, run in duplicate. Membranes were sequentially probed for Grp75, VADC1 (*VDAC1 band), and Actin (A-i) or Notch1, MCU and Actin (A-ii). Mean ± SD values below are the densitometry analysis of Grp75, VDAC1 and MCU relative to Actin. (B) Representative Z-projected confocal images of Notch1 +/+ and Notch1 -/- Tregs immune-stained with an antibody to Grp75 (green). scale bar: 5 μm. Images are representative of 106 Notch1 +/+ Tregs and 82 Notch1 -/- Tregs. (C) Relative transcript levels of indicated genes in Notch1 +/+ and Notch1 -/- activated Tregs. (D) Immunoblots of cell lysates from Notch1 -/- Tregs transduced with pBABE or NIC1-NES probed for Notch1, Grp75 and Actin. Mean ± SD values below are the densitometry analysis of Grp75 relative to Actin. (E) Percent apoptotic nuclei in Notch1 -/- Tregs transduced with pBABE or Grp75, cultured without IL-2 for 24 h with 5μM Xestospongin C or, 10 μM MKT-077 or, 10 μM Ru360. (F) Basal and maximum OCR in Notch1 -/- Tregs transduced with pBABE or Grp75. Control (pBABE) condition in panels E and F are common <xref ref-type= Figures 5B, D as these were tested in the same experiment, as described in methods . (G, H) Cell lysates of WT activated Tregs cultured for 6 h without IL-2 were subject to immunoprecipitation using an antibody to Notch1 (G) or Grp75 (H) or, IgG (Isotype control), and associated proteins analyzed by western blotting for Grp75, VDAC1 (*shows VDAC1), Notch1, Vps34, Actin and IgG (Isotype control). Immunoblots are representative of three independent experiments (A) or, two independent experiments (D, G, H) . Data show the mean ± SD of three independent experiments (C, E) and readings in 4 wells from two independent experiments (F). * and ** indicates significant difference with p-value ≤0.05 and ≤0.01 respectively, and ns: not significant, examined using unpaired student’s t-test. " width="100%" height="100%">

Journal: Frontiers in Immunology

Article Title: Notch1 Modulation of Cellular Calcium Regulates Mitochondrial Metabolism and Anti-Apoptotic Activity in T-Regulatory Cells

doi: 10.3389/fimmu.2022.832159

Figure Lengend Snippet: Notch1 activity regulates Grp75 protein levels. (A) Immunoblots of whole cell lysates prepared from activated Notch1 +/+ (Cre-ve) and Notch1 -/- (Cre+ve; Cd4-Cre::Notch1 lox/lox ) Tregs, run in duplicate. Membranes were sequentially probed for Grp75, VADC1 (*VDAC1 band), and Actin (A-i) or Notch1, MCU and Actin (A-ii). Mean ± SD values below are the densitometry analysis of Grp75, VDAC1 and MCU relative to Actin. (B) Representative Z-projected confocal images of Notch1 +/+ and Notch1 -/- Tregs immune-stained with an antibody to Grp75 (green). scale bar: 5 μm. Images are representative of 106 Notch1 +/+ Tregs and 82 Notch1 -/- Tregs. (C) Relative transcript levels of indicated genes in Notch1 +/+ and Notch1 -/- activated Tregs. (D) Immunoblots of cell lysates from Notch1 -/- Tregs transduced with pBABE or NIC1-NES probed for Notch1, Grp75 and Actin. Mean ± SD values below are the densitometry analysis of Grp75 relative to Actin. (E) Percent apoptotic nuclei in Notch1 -/- Tregs transduced with pBABE or Grp75, cultured without IL-2 for 24 h with 5μM Xestospongin C or, 10 μM MKT-077 or, 10 μM Ru360. (F) Basal and maximum OCR in Notch1 -/- Tregs transduced with pBABE or Grp75. Control (pBABE) condition in panels E and F are common Figures 5B, D as these were tested in the same experiment, as described in methods . (G, H) Cell lysates of WT activated Tregs cultured for 6 h without IL-2 were subject to immunoprecipitation using an antibody to Notch1 (G) or Grp75 (H) or, IgG (Isotype control), and associated proteins analyzed by western blotting for Grp75, VDAC1 (*shows VDAC1), Notch1, Vps34, Actin and IgG (Isotype control). Immunoblots are representative of three independent experiments (A) or, two independent experiments (D, G, H) . Data show the mean ± SD of three independent experiments (C, E) and readings in 4 wells from two independent experiments (F). * and ** indicates significant difference with p-value ≤0.05 and ≤0.01 respectively, and ns: not significant, examined using unpaired student’s t-test.

Article Snippet: Human Grp75 Tagged ORF Clone was obtained from Origene (RG201397, MD, USA) and sub-cloned into pBABE vector.

Techniques: Activity Assay, Western Blot, Staining, Transduction, Cell Culture, Control, Immunoprecipitation

Summary of key outcomes. Non-nuclear localized NIC1 interacts with Grp75 and VDAC1 in a complex that modulates calcium homeostasis in mitochondria with consequences to cellular metabolism and survival. The schematic is not to scale.

Journal: Frontiers in Immunology

Article Title: Notch1 Modulation of Cellular Calcium Regulates Mitochondrial Metabolism and Anti-Apoptotic Activity in T-Regulatory Cells

doi: 10.3389/fimmu.2022.832159

Figure Lengend Snippet: Summary of key outcomes. Non-nuclear localized NIC1 interacts with Grp75 and VDAC1 in a complex that modulates calcium homeostasis in mitochondria with consequences to cellular metabolism and survival. The schematic is not to scale.

Article Snippet: Human Grp75 Tagged ORF Clone was obtained from Origene (RG201397, MD, USA) and sub-cloned into pBABE vector.

Techniques:

Figure 5. S100a8/9 activated calcineurin/NFAT signaling pathway during phenylephrine-induced hypertrophy of cardiomyocytes in vitro. A, Cell areas of NRCMs treated with several inhibitors of hypertrophy-related kinases (n=5). cyclosporin A (an inhibitor of calcineurin), VIVIT (an inhibitor of NFAT), CCT129957 (an inhibitor of PLCγ), PD169316 (an inhibitor of p38), SP600125 (an inhibitor of JNK), U0126 (an inhibitor of ERK), BMS-345541 (an inhibitor of NF-κB), and AKTi (an inhibitor of AKT) were used. B, mRNA levels of atrial natriuretic peptide (ANP) in indicated groups (n=5). C and D, Calcineurin activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). E and F, NFAT transcriptional activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). G and H, mRNA level of calcineurin 1 (RCAN1) in the hearts following AB with overexpression or knockdown of S100a9 (n=6). I, Representative Western blots and the statistical results of the protein levels (n=6). Values represent the mean±SEM. *P<0.05 vs the matched control group. AB indicates aortic banding; ANP, atrial natriuretic peptide; NF-κB, nuclear factor-κB; NFAT, nuclear factor of activated T cells; NRCM, neonatal rat cardiomyocyte; PCNA, proliferating cell nuclear antigen; PLCγ, phospholipase C-γ; P-PLCγ, phospho-PLCγ; RCAN1, regulator of calcineurin 1; and S100a8/9, S100 calcium binding protein a8/9.

Journal: Journal of the American Heart Association

Article Title: S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice

doi: 10.1161/jaha.122.028006

Figure Lengend Snippet: Figure 5. S100a8/9 activated calcineurin/NFAT signaling pathway during phenylephrine-induced hypertrophy of cardiomyocytes in vitro. A, Cell areas of NRCMs treated with several inhibitors of hypertrophy-related kinases (n=5). cyclosporin A (an inhibitor of calcineurin), VIVIT (an inhibitor of NFAT), CCT129957 (an inhibitor of PLCγ), PD169316 (an inhibitor of p38), SP600125 (an inhibitor of JNK), U0126 (an inhibitor of ERK), BMS-345541 (an inhibitor of NF-κB), and AKTi (an inhibitor of AKT) were used. B, mRNA levels of atrial natriuretic peptide (ANP) in indicated groups (n=5). C and D, Calcineurin activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). E and F, NFAT transcriptional activity in the hearts following AB with overexpression or knockdown of S100a9 (n=6). G and H, mRNA level of calcineurin 1 (RCAN1) in the hearts following AB with overexpression or knockdown of S100a9 (n=6). I, Representative Western blots and the statistical results of the protein levels (n=6). Values represent the mean±SEM. *P<0.05 vs the matched control group. AB indicates aortic banding; ANP, atrial natriuretic peptide; NF-κB, nuclear factor-κB; NFAT, nuclear factor of activated T cells; NRCM, neonatal rat cardiomyocyte; PCNA, proliferating cell nuclear antigen; PLCγ, phospholipase C-γ; P-PLCγ, phospho-PLCγ; RCAN1, regulator of calcineurin 1; and S100a8/9, S100 calcium binding protein a8/9.

Article Snippet: The inhibitors, PD169316, SP600125, U0126, VIVIT, AKTi, CCT129957, and cyclosporin A were purchased from MedChemExpress (Wuhan, China).

Techniques: In Vitro, Activity Assay, Over Expression, Knockdown, Western Blot, Control, Binding Assay

Pedigree and genetic mutation of the family with keratoconus and congenital cataracts. ( A ) Pedigree. ( B ) Sanger sequencing confirms the c.394-398del (p. L132Nfs*6) mutation identified by WES (I-2 and II-1) and HRM (KC5). ( C ) Cross-species comparison of the region of ERCC8 indicates that the identified mutation affects highly conserved residues. ( D ) Domain analysis of the p. L132Nfs*6 mutation. ( E ) The 3D structures of mutant and wild type protein.

Journal: Investigative Ophthalmology & Visual Science

Article Title: Insufficient Dose of ERCC8 Protein Caused by a Frameshift Mutation Is Associated With Keratoconus With Congenital Cataracts

doi: 10.1167/iovs.63.13.1

Figure Lengend Snippet: Pedigree and genetic mutation of the family with keratoconus and congenital cataracts. ( A ) Pedigree. ( B ) Sanger sequencing confirms the c.394-398del (p. L132Nfs*6) mutation identified by WES (I-2 and II-1) and HRM (KC5). ( C ) Cross-species comparison of the region of ERCC8 indicates that the identified mutation affects highly conserved residues. ( D ) Domain analysis of the p. L132Nfs*6 mutation. ( E ) The 3D structures of mutant and wild type protein.

Article Snippet: Primary antibodies included those of collagen IV (ab6586; Abcam), ERCC8 (sc-376981; Santa Cruz), SOD1 (MABC684; Millipore), γ-H2AX (AP0099; Abclonal), NF-kB p65 (phosphor S536, ab76302; Abcam), MMP1 (ab52631; Abcam), Caspase 3 (D320074; Sangon), and GAPDH (KC-5G5; Kangchen, Shanghai, China).

Techniques: Mutagenesis, Sequencing, Comparison

Pathogenicity Assessment of  ERCC8  Mutation

Journal: Investigative Ophthalmology & Visual Science

Article Title: Insufficient Dose of ERCC8 Protein Caused by a Frameshift Mutation Is Associated With Keratoconus With Congenital Cataracts

doi: 10.1167/iovs.63.13.1

Figure Lengend Snippet: Pathogenicity Assessment of ERCC8 Mutation

Article Snippet: Primary antibodies included those of collagen IV (ab6586; Abcam), ERCC8 (sc-376981; Santa Cruz), SOD1 (MABC684; Millipore), γ-H2AX (AP0099; Abclonal), NF-kB p65 (phosphor S536, ab76302; Abcam), MMP1 (ab52631; Abcam), Caspase 3 (D320074; Sangon), and GAPDH (KC-5G5; Kangchen, Shanghai, China).

Techniques: Mutagenesis, Sequencing, Control

Expression of ERCC8 in different mouse tissues. ( A ) Representative figures of immunofluorescence staining of ERCC8 in the mouse eye (the upper was a panoramic image, and the lower were local images). ( B ) The mRNA expression levels of ERCC8 in different mouse tissues.

Journal: Investigative Ophthalmology & Visual Science

Article Title: Insufficient Dose of ERCC8 Protein Caused by a Frameshift Mutation Is Associated With Keratoconus With Congenital Cataracts

doi: 10.1167/iovs.63.13.1

Figure Lengend Snippet: Expression of ERCC8 in different mouse tissues. ( A ) Representative figures of immunofluorescence staining of ERCC8 in the mouse eye (the upper was a panoramic image, and the lower were local images). ( B ) The mRNA expression levels of ERCC8 in different mouse tissues.

Article Snippet: Primary antibodies included those of collagen IV (ab6586; Abcam), ERCC8 (sc-376981; Santa Cruz), SOD1 (MABC684; Millipore), γ-H2AX (AP0099; Abclonal), NF-kB p65 (phosphor S536, ab76302; Abcam), MMP1 (ab52631; Abcam), Caspase 3 (D320074; Sangon), and GAPDH (KC-5G5; Kangchen, Shanghai, China).

Techniques: Expressing, Immunofluorescence, Staining

Mutant ERCC8 constructs and expression in human embryonic kidney 293 cells. ( A ) The fluorescence intensity of GFP after transfection for 48 hours. ( B ) mRNA expression levels of ERCC8 and TCR-related genes ( CSB , XPA , RPA , and XPG ) in overexpressed wild type and mutant cells. ( C ) Western blot results of ERCC8 protein in overexpressed wild type and mutant cells. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Journal: Investigative Ophthalmology & Visual Science

Article Title: Insufficient Dose of ERCC8 Protein Caused by a Frameshift Mutation Is Associated With Keratoconus With Congenital Cataracts

doi: 10.1167/iovs.63.13.1

Figure Lengend Snippet: Mutant ERCC8 constructs and expression in human embryonic kidney 293 cells. ( A ) The fluorescence intensity of GFP after transfection for 48 hours. ( B ) mRNA expression levels of ERCC8 and TCR-related genes ( CSB , XPA , RPA , and XPG ) in overexpressed wild type and mutant cells. ( C ) Western blot results of ERCC8 protein in overexpressed wild type and mutant cells. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Article Snippet: Primary antibodies included those of collagen IV (ab6586; Abcam), ERCC8 (sc-376981; Santa Cruz), SOD1 (MABC684; Millipore), γ-H2AX (AP0099; Abclonal), NF-kB p65 (phosphor S536, ab76302; Abcam), MMP1 (ab52631; Abcam), Caspase 3 (D320074; Sangon), and GAPDH (KC-5G5; Kangchen, Shanghai, China).

Techniques: Mutagenesis, Construct, Expressing, Fluorescence, Transfection, Western Blot

Knockdown of ERCC8 in human corneal fibroblast cells. ( A ) The mRNA expression levels of ERCC8 after being transfected by ERCC8 siRNA. ( B ) The mRNA expression levels of TCR-related genes ( CSB , XPA , RPA , and XPG ) after being transfected by ERCC8 siRNA. ( C ) Western blot results of ERCC8, collagen Ⅳ, and SOD1 proteins after being transfected by ERCC8 siRNA. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Journal: Investigative Ophthalmology & Visual Science

Article Title: Insufficient Dose of ERCC8 Protein Caused by a Frameshift Mutation Is Associated With Keratoconus With Congenital Cataracts

doi: 10.1167/iovs.63.13.1

Figure Lengend Snippet: Knockdown of ERCC8 in human corneal fibroblast cells. ( A ) The mRNA expression levels of ERCC8 after being transfected by ERCC8 siRNA. ( B ) The mRNA expression levels of TCR-related genes ( CSB , XPA , RPA , and XPG ) after being transfected by ERCC8 siRNA. ( C ) Western blot results of ERCC8, collagen Ⅳ, and SOD1 proteins after being transfected by ERCC8 siRNA. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Article Snippet: Primary antibodies included those of collagen IV (ab6586; Abcam), ERCC8 (sc-376981; Santa Cruz), SOD1 (MABC684; Millipore), γ-H2AX (AP0099; Abclonal), NF-kB p65 (phosphor S536, ab76302; Abcam), MMP1 (ab52631; Abcam), Caspase 3 (D320074; Sangon), and GAPDH (KC-5G5; Kangchen, Shanghai, China).

Techniques: Knockdown, Expressing, Transfection, Western Blot

Cell viability and DNA damage assays of HTK treated by H 2 O 2 after ERCC8 siRNA transfection. ( A ) Cell viability assay results. ( B ) Hoechst staining results. ( C ) Western blot results of ERCC8, γ- H2AX, and phospho p65 protein. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Journal: Investigative Ophthalmology & Visual Science

Article Title: Insufficient Dose of ERCC8 Protein Caused by a Frameshift Mutation Is Associated With Keratoconus With Congenital Cataracts

doi: 10.1167/iovs.63.13.1

Figure Lengend Snippet: Cell viability and DNA damage assays of HTK treated by H 2 O 2 after ERCC8 siRNA transfection. ( A ) Cell viability assay results. ( B ) Hoechst staining results. ( C ) Western blot results of ERCC8, γ- H2AX, and phospho p65 protein. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Article Snippet: Primary antibodies included those of collagen IV (ab6586; Abcam), ERCC8 (sc-376981; Santa Cruz), SOD1 (MABC684; Millipore), γ-H2AX (AP0099; Abclonal), NF-kB p65 (phosphor S536, ab76302; Abcam), MMP1 (ab52631; Abcam), Caspase 3 (D320074; Sangon), and GAPDH (KC-5G5; Kangchen, Shanghai, China).

Techniques: Transfection, Viability Assay, Staining, Western Blot

Cell viability, apoptosis, and DNA damage assays of HLECs treated by H 2 O 2 after ERCC8 siRNA transfection. ( A ) Cell viability assay results. ( B ) The mRNA expression levels of TCR-related genes. ( C ) Representative figures of immunofluorescence staining of cell apoptosis. ( D ) Statistical results of the cell apoptosis analysis. ( E ) The mRNA expression levels of UPR-related genes. ( F ) Western blot results of SOD1, γ- H2AX, and caspase 3 protein. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Journal: Investigative Ophthalmology & Visual Science

Article Title: Insufficient Dose of ERCC8 Protein Caused by a Frameshift Mutation Is Associated With Keratoconus With Congenital Cataracts

doi: 10.1167/iovs.63.13.1

Figure Lengend Snippet: Cell viability, apoptosis, and DNA damage assays of HLECs treated by H 2 O 2 after ERCC8 siRNA transfection. ( A ) Cell viability assay results. ( B ) The mRNA expression levels of TCR-related genes. ( C ) Representative figures of immunofluorescence staining of cell apoptosis. ( D ) Statistical results of the cell apoptosis analysis. ( E ) The mRNA expression levels of UPR-related genes. ( F ) Western blot results of SOD1, γ- H2AX, and caspase 3 protein. ( D ) Statistical results of the Western blot; N = 3, *, P < 0.05.

Article Snippet: Primary antibodies included those of collagen IV (ab6586; Abcam), ERCC8 (sc-376981; Santa Cruz), SOD1 (MABC684; Millipore), γ-H2AX (AP0099; Abclonal), NF-kB p65 (phosphor S536, ab76302; Abcam), MMP1 (ab52631; Abcam), Caspase 3 (D320074; Sangon), and GAPDH (KC-5G5; Kangchen, Shanghai, China).

Techniques: Transfection, Viability Assay, Expressing, Immunofluorescence, Staining, Western Blot

( A ) Schematic of capturing EBERs ncRNA cofactors via annotated tandem (MS2) mass spectrum. ( B ) The scatter plot displays the cofactors associated with EBERs ncRNA captured by MASS. ( C ) GO term enrichment analysis of EBERs cofactors. The x -axis represents -log10 (P-value) from the hypergeometric test. ( D ) Display of the binding peak of EBV cofactors HSPA9 and NCL in EBERs -NC cells and EBERs -KD cells, overlapping with EBERs-binding peaks. ( E ) Display of the binding peak of EBERs , without detecting peaks of cofactors NCL in EBERs -KD cells and EBERs -NC cells. ( F ) Bar charts display the proportion of cofactors HSPA9 and NCL that overlapped with EBERs targeting regions. n indicates the total number of peaks for HSPA9 and NCL captured by ChIP-seq. ( G ) Box plots illustrating the change of binding signal of HSPA9 and NCL before and after EBERs knockdown. Two-sided Wilcoxon tests are performed. Each box plot highlights the median (inside line), the 25–75th percentiles (box), and the minima/maxima values within 1.5× the interquartile range (IQR) of the box (whiskers). ( H ) Schematic representation of NCL-interacted chromatin RNA assay (termed NCL-RNA). ( I ) Basic Browser View of EBERs ncRNA and mRNA, such as LMP-2, as observed in RNA-seq and NCL-RNA. ( J ) Enrichment analysis of EBERs ncRNA is depicted by the ratio of RPKM of EBERs compared to other mRNAs, with t tests performed. Bars represent the mean values of the data, while error bars indicate the standard deviation (SD). ( K ) Schematic illustration of NCL truncations and the principle of EMSA. ( L ) EMSA results demonstrate the interaction at varying concentrations of NCL protein mixed with 1 μM EBERs . .

Journal: The EMBO Journal

Article Title: Landscape of the Epstein-Barr virus-host chromatin interactome and gene regulation

doi: 10.1038/s44318-025-00466-5

Figure Lengend Snippet: ( A ) Schematic of capturing EBERs ncRNA cofactors via annotated tandem (MS2) mass spectrum. ( B ) The scatter plot displays the cofactors associated with EBERs ncRNA captured by MASS. ( C ) GO term enrichment analysis of EBERs cofactors. The x -axis represents -log10 (P-value) from the hypergeometric test. ( D ) Display of the binding peak of EBV cofactors HSPA9 and NCL in EBERs -NC cells and EBERs -KD cells, overlapping with EBERs-binding peaks. ( E ) Display of the binding peak of EBERs , without detecting peaks of cofactors NCL in EBERs -KD cells and EBERs -NC cells. ( F ) Bar charts display the proportion of cofactors HSPA9 and NCL that overlapped with EBERs targeting regions. n indicates the total number of peaks for HSPA9 and NCL captured by ChIP-seq. ( G ) Box plots illustrating the change of binding signal of HSPA9 and NCL before and after EBERs knockdown. Two-sided Wilcoxon tests are performed. Each box plot highlights the median (inside line), the 25–75th percentiles (box), and the minima/maxima values within 1.5× the interquartile range (IQR) of the box (whiskers). ( H ) Schematic representation of NCL-interacted chromatin RNA assay (termed NCL-RNA). ( I ) Basic Browser View of EBERs ncRNA and mRNA, such as LMP-2, as observed in RNA-seq and NCL-RNA. ( J ) Enrichment analysis of EBERs ncRNA is depicted by the ratio of RPKM of EBERs compared to other mRNAs, with t tests performed. Bars represent the mean values of the data, while error bars indicate the standard deviation (SD). ( K ) Schematic illustration of NCL truncations and the principle of EMSA. ( L ) EMSA results demonstrate the interaction at varying concentrations of NCL protein mixed with 1 μM EBERs . .

Article Snippet: Anti-HSPA9 antibody , Abclonal , A0558.

Techniques: Binding Assay, ChIP-sequencing, Knockdown, RNA Sequencing, Standard Deviation

( A – C ) Scatter plots demonstrating the reproducibility of NCL ChIP-seq ( A ), HSPA9 ChIP-seq ( B ), and NCL-interacted chromatin RNA assay captured EBV gene expression associated with NCL protein ( C ) in EBERs -NC and EBERs -KD. ( D ) Volcano plot illustrating the enrichment of NCL-bound RNAs identified by the NCL-RNA assay compared to RNA-seq. The x-axis represents the log2 fold change (NCL-RNA vs. RNA-seq), while the y axis represents the -log10 P-value from the likelihood ratio test. RNAs enriched in the NCL-RNA data are shown on the right side of the plot, with significantly enriched RNAs highlighted as red points above the horizontal dashed line ( P < 0.05). The bracket marks the region containing NCL-enriched RNAs. ( E ) Scatter plot showing the gene expression levels (FPKM) of NCL-RNA and RNA-seq, corresponding to ( D ). The scatter plot supplements the volcano plot by providing the original expression levels, which are not visible in the volcano plot. n represents the number of genes. ( F ) Western blot showing the knockdown efficiency of NCL using siRNA, with GAPDH as the control. ( G ) Scatter plots illustrating the reproducibility of ATAC-seq in EBERs -NC and EBERs -KD. “Rep” denotes replicate.

Journal: The EMBO Journal

Article Title: Landscape of the Epstein-Barr virus-host chromatin interactome and gene regulation

doi: 10.1038/s44318-025-00466-5

Figure Lengend Snippet: ( A – C ) Scatter plots demonstrating the reproducibility of NCL ChIP-seq ( A ), HSPA9 ChIP-seq ( B ), and NCL-interacted chromatin RNA assay captured EBV gene expression associated with NCL protein ( C ) in EBERs -NC and EBERs -KD. ( D ) Volcano plot illustrating the enrichment of NCL-bound RNAs identified by the NCL-RNA assay compared to RNA-seq. The x-axis represents the log2 fold change (NCL-RNA vs. RNA-seq), while the y axis represents the -log10 P-value from the likelihood ratio test. RNAs enriched in the NCL-RNA data are shown on the right side of the plot, with significantly enriched RNAs highlighted as red points above the horizontal dashed line ( P < 0.05). The bracket marks the region containing NCL-enriched RNAs. ( E ) Scatter plot showing the gene expression levels (FPKM) of NCL-RNA and RNA-seq, corresponding to ( D ). The scatter plot supplements the volcano plot by providing the original expression levels, which are not visible in the volcano plot. n represents the number of genes. ( F ) Western blot showing the knockdown efficiency of NCL using siRNA, with GAPDH as the control. ( G ) Scatter plots illustrating the reproducibility of ATAC-seq in EBERs -NC and EBERs -KD. “Rep” denotes replicate.

Article Snippet: Anti-HSPA9 antibody , Abclonal , A0558.

Techniques: ChIP-sequencing, Gene Expression, RNA Sequencing, Expressing, Western Blot, Knockdown, Control

( A ) Basic Browser View illustrating changes in chromatin interactions upon the downregulation of EBERs or NCL. ( B ) Violin box plot displaying alterations in chromatin interactions: ( i ) RNAPII-associated chromatin in EBERs target regions between EBERs -NC and EBERs -KD groups, ( ii ) NCL-associated chromatin in EBERs target regions between EBERs -NC and EBERs -KD groups, ( iii ) RNAPII-associated chromatin between NCL-NC and NCL-KD groups. The number of chromatin loops overlapping these target regions is denoted by ‘ n ’. And ( iv ) changes in chromatin accessibility of EBERs -NC (yellow) compared to EBERs -KD (orange) at NCL binding regions, obtained from EBERs -NC ( n = 291) and EBERs -KD ( n = 336). Statistical significance was assessed using the Wilcoxon test, with P values displayed above the plots. Each box plot highlights the median (inside line), the 25th to 75th percentiles (box), and the minima/maxima values within 1.5× the interquartile range (IQR) of the box (whiskers). ( C ) The mechanistic model is presented: The left panel illustrates the interactions between EBERs , HSPA9, and NCL, which inhibit the RNAPII-associated chromatin loop to repress gene expression. The right panel shows an increase in gene expression following the reduction of EBERs and subsequently NCL, thereby alleviating the inhibition of the RNAPII-associated chromatin loop. ( D ) The model of the interactome between EBV and the host human GM12878 cells. On the left, the EBV 3D structure is depicted; in the middle, the interaction between EBV and the host is shown, along with the enriched key functions and pathways; on the right, the dynamic chromatin extrusion model of ncRNAs and proteins is illustrated, highlighting their targeting to chromatin with low accessibility. .

Journal: The EMBO Journal

Article Title: Landscape of the Epstein-Barr virus-host chromatin interactome and gene regulation

doi: 10.1038/s44318-025-00466-5

Figure Lengend Snippet: ( A ) Basic Browser View illustrating changes in chromatin interactions upon the downregulation of EBERs or NCL. ( B ) Violin box plot displaying alterations in chromatin interactions: ( i ) RNAPII-associated chromatin in EBERs target regions between EBERs -NC and EBERs -KD groups, ( ii ) NCL-associated chromatin in EBERs target regions between EBERs -NC and EBERs -KD groups, ( iii ) RNAPII-associated chromatin between NCL-NC and NCL-KD groups. The number of chromatin loops overlapping these target regions is denoted by ‘ n ’. And ( iv ) changes in chromatin accessibility of EBERs -NC (yellow) compared to EBERs -KD (orange) at NCL binding regions, obtained from EBERs -NC ( n = 291) and EBERs -KD ( n = 336). Statistical significance was assessed using the Wilcoxon test, with P values displayed above the plots. Each box plot highlights the median (inside line), the 25th to 75th percentiles (box), and the minima/maxima values within 1.5× the interquartile range (IQR) of the box (whiskers). ( C ) The mechanistic model is presented: The left panel illustrates the interactions between EBERs , HSPA9, and NCL, which inhibit the RNAPII-associated chromatin loop to repress gene expression. The right panel shows an increase in gene expression following the reduction of EBERs and subsequently NCL, thereby alleviating the inhibition of the RNAPII-associated chromatin loop. ( D ) The model of the interactome between EBV and the host human GM12878 cells. On the left, the EBV 3D structure is depicted; in the middle, the interaction between EBV and the host is shown, along with the enriched key functions and pathways; on the right, the dynamic chromatin extrusion model of ncRNAs and proteins is illustrated, highlighting their targeting to chromatin with low accessibility. .

Article Snippet: Anti-HSPA9 antibody , Abclonal , A0558.

Techniques: Binding Assay, Gene Expression, Inhibition